Mechanistic appraisal of the effects of some protease inhibitors on ciliary beat frequency in a sequential cell culture system of human nasal epithelium

被引:11
作者
Agu, RU
Jorissen, M
Willems, T
Kinget, R
Verbeke, N
机构
[1] Katholieke Univ Leuven, Lab Farmacotechnol & Biofarm, B-3000 Louvain, Belgium
[2] Lab Expt Otorhinolaryngol, Louvain, Belgium
关键词
nasal drug delivery; cell culture; ciliary beat frequency; ciliotoxicity; protease inhibitors;
D O I
10.1016/S0939-6411(03)00023-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to investigate the suitability of a sequential monolayer-suspension culture system as a model to screen subacute effects of drug excipients on ciliary beat frequency (CBF). The CBF of the cultured cells was measured by computerized microscope photometry. Protease inhibitors (puromycin, bestatin, bacitracin, actinonin and thiomersal) were used as model compounds and the mechanisms of ciliary inhibition were investigated by probing the involvement of arachidonic acid metabolism, guanylate cyclase (cGMP), protein kinase C (PKC) and adenosinetriphosphate (ATP) inhibition. Bestatin concentration-dependently reduced CBF by inhibiting arachidonic acid metabolism, cGMP, PKC and endogenous ATP consumption. Thiomersal and DMSO used for dissolving actinonin reduced CBF (P < 0.05) via a non-specific mechanism. Bacitracin (8 mM) and puromycin (135 mM) had no effect on CBF after acute exposure (15-30 min) (P > 0.05), but significantly reduced the CBF by approximately 15.0% following daily15-min exposure for 1 week. This study shows that (i) sequential monolayer-suspension culture system is a valid model to screen both acute and subacute effects of drug excipients on CBF; and (ii) bacitracin, puromycin and actinonin are more cilio-compatible than bestatin and thiomersal and as such are more potentially useful nasal absorption enhancer from ciliotoxicity perspective. (C) 2003 Published by Elsevier Science B.V.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 28 条
  • [1] Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium
    Agu, RU
    Dang, HV
    Jorissen, M
    Willems, T
    Kinget, R
    Verbeke, N
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 237 (1-2) : 179 - 191
  • [2] Agu RU, 2002, STP PHARMA SCI, V12, P13
  • [3] Agu RU, 1999, PHARMACEUT RES, V16, P1380
  • [4] Safety assessment of selected cyclodextrins - effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis
    Agu, RU
    Jorissen, M
    Willems, T
    Van den Mooter, G
    Kinget, R
    Verbeke, N
    Augustijns, P
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 193 (02) : 219 - 226
  • [5] The effect of chronic nasal application of chitosan solutions on cilia beat frequency in guinea pigs
    Aspden, T
    Illum, L
    Skaugrud, O
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 153 (02) : 137 - 146
  • [6] Ciliary beat frequency of human sphenoid sinus mucosa after cryopreservation
    Boek, WM
    Graamans, K
    Huizing, EH
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 1998, 255 (03) : 135 - 137
  • [7] CORNAZ AL, 1994, EUR J PHARM BIOPHARM, V40, P261
  • [8] Effect of oleoresin capsicum (OC) and ortho-chlorobenzylidene malononitrile (CS) on ciliary beat frequency
    Delamanche, S
    Desforges, P
    Morio, S
    Fuche, C
    Calvet, JH
    [J]. TOXICOLOGY, 2001, 165 (2-3) : 79 - 85
  • [9] COMPOSITE EFFECTS OF ACTINONIN WHEN INHIBITING ENKEPHALIN-DEGRADING ENZYMES
    HACHISU, M
    HIRANUMA, T
    SHIBAZAKI, Y
    UOTANI, K
    MURATA, S
    AOYAGI, T
    UMEZAWA, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 137 (01) : 59 - 65
  • [10] Airway goblet-cell mucus secretion
    Jackson, AD
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (01) : 39 - 45